BlackRock Fund Advisors’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $120M | Buy |
3,437,673
+273,278
| +9% | +$9.51M | 0.02% | 1063 |
|
|
2016
Q3 | $77.6M | Buy |
3,164,395
+163,791
| +5% | +$4.01M | 0.02% | 1274 |
|
|
2016
Q2 | $71.8M | Buy |
3,000,604
+70,170
| +2% | +$1.68M | 0.02% | 1250 |
|
|
2016
Q1 | $68.6M | Buy |
2,930,434
+1,529,853
| +109% | +$35.8M | 0.02% | 1239 |
|
|
2015
Q4 | $42.3M | Buy |
1,400,581
+435,075
| +45% | +$13.1M | 0.01% | 1586 |
|
|
2015
Q3 | $38.4M | Sell |
965,506
-5,655
| -0.6% | -$225K | 0.01% | 1591 |
|
|
2015
Q2 | $67.1M | Sell |
971,161
-42,931
| -4% | -$2.96M | 0.02% | 1311 |
|
|
2015
Q1 | $55.4M | Sell |
1,014,092
-7,790
| -0.8% | -$426K | 0.01% | 1440 |
|
|
2014
Q4 | $43.6M | Sell |
1,021,882
-25,851
| -2% | -$1.1M | 0.01% | 1550 |
|
|
2014
Q3 | $33.4M | Sell |
1,047,733
-44,090
| -4% | -$1.41M | 0.01% | 1627 |
|
|
2014
Q2 | $22.6M | Buy |
1,091,823
+87,839
| +9% | +$1.82M | 0.01% | 1948 |
|
|
2014
Q1 | $19.4M | Sell |
1,003,984
-1,583
| -0.2% | -$30.6K | 0.01% | 2010 |
|
|
2013
Q4 | $24.4M | Buy |
1,005,567
+24,266
| +2% | +$589K | 0.01% | 1874 |
|
|
2013
Q3 | $21.1M | Buy |
981,301
+80,832
| +9% | +$1.74M | 0.01% | 1934 |
|
|
2013
Q2 | $20M | Buy |
+900,469
| New | +$20M | 0.01% | 1856 |
|